Workflow
Momentum investing
icon
Search documents
What Makes MercadoLibre (MELI) a Strong Momentum Stock: Buy Now?
ZACKS· 2025-06-06 17:01
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: MercadoLibre (MELI) - MELI currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, MELI shares increased by 2.21%, outperforming the Zacks Internet - Commerce industry, which rose by 0.64% [5] - In a longer timeframe, MELI's shares have appreciated by 7.13% over the past month, compared to the industry's 1% [5] - Over the last quarter, MELI shares surged by 29.75%, and over the past year, they have gained 59.26%, while the S&P 500 only increased by 1.99% and 12.34%, respectively [6] Trading Volume - MELI's average 20-day trading volume is 312,518 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, 4 earnings estimates for MELI have been revised upwards, while only 2 were revised downwards, leading to an increase in the consensus estimate from $47.50 to $48.80 [9] - For the next fiscal year, 4 estimates have moved higher with no downward revisions, indicating a positive earnings outlook [9] Conclusion - Considering the positive performance metrics and earnings outlook, MELI is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a strong candidate for near-term investment [11]
Here's Why Avino Silver (ASM) is a Great Momentum Stock to Buy
ZACKS· 2025-06-06 17:01
Company Overview - Avino Silver (ASM) currently holds a Momentum Style Score of B, indicating a positive momentum outlook [3] - The company has a Zacks Rank of 1 (Strong Buy), suggesting strong potential for outperformance in the market [4] Price Performance - Over the past week, ASM shares have increased by 3.59%, outperforming the Zacks Mining - Silver industry, which rose by 0.91% [6] - In a longer time frame, ASM's monthly price change is 47.11%, compared to the industry's 31.85% [6] - Over the past quarter, ASM shares have risen by 101.13%, and over the last year, they have increased by 239.05% [7] - In contrast, the S&P 500 has only moved 1.99% and 12.34% over the same periods [7] Trading Volume - ASM's average 20-day trading volume is 4,669,188 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for ASM have been revised upwards, while none have been revised downwards, leading to an increase in the consensus estimate from $0.07 to $0.13 [10] - For the next fiscal year, one estimate has moved upwards with no downward revisions [10] Conclusion - Considering the positive price performance, trading volume, and earnings outlook, ASM is positioned as a strong buy with a Momentum Score of B, making it a compelling option for investors seeking short-term gains [12]
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy
ZACKS· 2025-06-06 17:01
Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2] - OptimizeRx Corp. (OPRX) currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] Price Performance - OPRX shares have increased by 4.21% over the past week, outperforming the Zacks Computer - Software industry, which rose by 1.28% [6] - Over the past month, OPRX's price has surged by 43.09%, significantly higher than the industry's 1.82% [6] - In the last quarter, OPRX shares rose by 98.32%, and over the past year, they increased by 25.6%, while the S&P 500 only moved 1.99% and 12.34%, respectively [7] Trading Volume - The average 20-day trading volume for OPRX is 396,163 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, four earnings estimates for OPRX have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $0.40 to $0.51 [10] - For the next fiscal year, three estimates have also moved higher, indicating positive sentiment regarding future earnings [10] Conclusion - Given the strong price performance, positive earnings outlook, and favorable momentum indicators, OPRX is positioned as a promising investment opportunity [12]
I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-06-06 17:01
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...
Breakout Momentum Plays You May Not Know About
MarketBeat· 2025-06-06 15:54
Group 1: Market Overview - High volatility in markets throughout 2025 has created opportunities for momentum investors to capture gains when target stocks rise [1] - Timing momentum plays can be challenging, but early identification of targets in a sustained rally can provide an advantage [1] Group 2: EyePoint Pharmaceuticals (EYPT) - EyePoint Pharmaceuticals, a clinical-stage biopharma firm, has seen its stock price forecasted to reach $25.38, indicating a potential upside of 188.39% from the current price of $8.80 [2] - The company reported first-quarter revenue of nearly $25 million, significantly exceeding analyst expectations of just under $9 million [3] - EyePoint's lead drug candidate, DURAVYU, is in a critical Phase 3 clinical trial, with top-line data expected in 2026 [4] - The company ended the first quarter with over $318 million in cash and investments, sufficient to sustain operations through 2027 [4] - EYPT shares have increased by more than 19% in the last month, with analysts suggesting that growth is just beginning [5] Group 3: Nova Ltd. (NVMI) - Nova Ltd., which designs process control systems for semiconductor manufacturing, has a stock price forecast of $277, representing a 26.02% upside from the current price of $219.81 [6] - The company reported quarterly revenue growth of over 50% year-over-year, with earnings per share of $2.18 beating analyst estimates by 10 cents [7] - Analysts project Nova's earnings growth could exceed 7% in the future, supported by a year-over-year cash flow growth of about 32% [8] - NVMI shares have risen by more than 10% in the last month, with a consensus price target suggesting over 27% upside potential [9] Group 4: Ouster Inc. (OUST) - Ouster Inc. specializes in LiDAR technology for 3D mapping and imaging, with a stock price forecast of $14.10, indicating a 2.45% upside from the current price of $13.76 [10] - The company reported first-quarter revenue of $33 million, a 26% year-over-year increase, and a GAAP gross margin improvement to 41% from 29% [11] - Ouster projects second-quarter revenue between $32 million and $35 million, indicating significant upside potential [11] - The company's stock has rallied over 71% in the last year, with analysts optimistic about further growth due to increasing demand for robotics and automation services [12]
Here's Why Donaldson (DCI) is a Strong Momentum Stock
ZACKS· 2025-06-06 14:51
Core Insights - Zacks Premium provides tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores rate stocks based on value, growth, and momentum, serving as complementary indicators to the Zacks Rank, helping investors identify securities likely to outperform the market in the short term [2][3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Style Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Cash Flow [3] Growth Score - The Growth Style Score assesses a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Style Score identifies optimal entry points for stocks based on price trends and earnings estimate changes [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator for evaluating stocks based on value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that utilizes earnings estimate revisions to guide investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +25.41%, significantly outperforming the S&P 500 [8] Stock Selection Strategy - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] - Stocks with a 3 (Hold) rank should also have Style Scores of A or B to ensure potential upside [10] Company Spotlight: Donaldson Company, Inc. - Donaldson Company, Inc. is a manufacturer of filtration systems and replacement parts, currently holding a Zacks Rank of 3 (Hold) with a VGM Score of B [12] - The company has a Momentum Style Score of A, with shares increasing by 3.3% over the past four weeks [12] - Recent analyst revisions have positively impacted earnings estimates for fiscal 2025, with the Zacks Consensus Estimate rising to $3.65 per share [13]
Despite Fast-paced Momentum, Sleep Number (SNBR) Is Still a Bargain Stock
ZACKS· 2025-06-06 13:51
Group 1 - Momentum investing is characterized by the strategy of "buying high and selling higher," contrasting with the traditional "buy low and sell high" approach [1] - Identifying the right entry point for momentum stocks can be challenging, as they may lose momentum if their valuations exceed future growth potential [1] - Investing in bargain stocks that have recently shown price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [2] Group 2 - Sleep Number (SNBR) has demonstrated significant price movement, with a 25.5% increase over the past four weeks, indicating growing investor interest [3] - Over a longer timeframe, SNBR has gained 54.2% in the past 12 weeks, showcasing its ability to deliver sustained positive returns [4] - SNBR has a Momentum Score of B, suggesting it is an opportune time to invest in the stock to capitalize on its momentum [5] Group 3 - SNBR has received a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which typically attract more investor interest and drive prices higher [6] - The stock is currently trading at a Price-to-Sales ratio of 0.14, indicating it is undervalued, as investors pay only 14 cents for each dollar of sales [6] - SNBR appears to have significant growth potential, supported by its fast-paced momentum characteristics [7] Group 4 - In addition to SNBR, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles, which can assist in identifying winning stock picks [8]
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
ZACKS· 2025-06-06 13:51
Group 1: Momentum Investing Overview - Momentum investing contrasts with the traditional "buy low and sell high" strategy, focusing instead on "buying high and selling higher" to capitalize on fast-moving stocks [1] - Identifying the right entry point for trending stocks can be challenging, as they may lose momentum if future growth does not justify their high valuations [1] Group 2: Investment Strategy - Investing in bargain stocks that have recently shown price momentum may be a safer approach [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Century Therapeutics, Inc. (IPSC) Analysis - Century Therapeutics, Inc. (IPSC) has shown a price increase of 8.3% over the past four weeks, indicating growing investor interest [3] - IPSC has gained 0.8% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - The stock has a beta of 1.77, suggesting it moves 77% higher than the market in either direction, indicating fast-paced momentum [4] Group 4: Valuation and Earnings Estimates - IPSC has a Momentum Score of A, suggesting it is an opportune time to invest in the stock [5] - The stock has a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which attract more investor interest [6] - IPSC is trading at a Price-to-Sales ratio of 0.42, indicating it is relatively cheap at 42 cents for each dollar of sales [6] Group 5: Additional Investment Opportunities - IPSC has significant potential for growth, and there are other stocks that meet the 'Fast-Paced Momentum at a Bargain' criteria [7] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify winning stock picks [8]
Perimeter Solutions, SA (PRM) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-06-05 17:05
Company Overview - Perimeter Solutions, SA (PRM) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The company has shown strong price performance, with shares up 30.46% over the past three months and 63.33% over the last year [7] Price Performance - Over the past week, PRM shares increased by 2.9%, outperforming the Zacks Chemical - Specialty industry, which rose by 1.03% [6] - The monthly price change for PRM is 19.51%, significantly higher than the industry's 4.62% [6] Trading Volume - PRM's average 20-day trading volume is 1,019,817 shares, indicating a bullish trend when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for PRM has moved higher, increasing the consensus estimate from $0.68 to $1.14 [10] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [10]
Monday.com (MNDY) Is Up 3.08% in One Week: What You Should Know
ZACKS· 2025-06-05 17:05
Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the aim of buying high and selling higher, capitalizing on established price movements [1][2] - The Zacks Momentum Style Score helps investors identify effective metrics for assessing momentum in stocks [2] Group 2: Company Analysis - Monday.com (MNDY) - Monday.com currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - Over the past week, MNDY shares increased by 3.08%, outperforming the Zacks Internet - Software industry, which rose by 0.76% [6] - In the last three months, MNDY shares rose by 22.08%, and over the past year, they increased by 41.24%, significantly outperforming the S&P 500's gains of 3.59% and 14.21% respectively [7] Group 3: Trading Volume and Earnings Outlook - MNDY's average 20-day trading volume is 653,366 shares, which serves as a bullish indicator when combined with rising stock prices [8] - In the past two months, 9 earnings estimates for MNDY have been revised upwards, increasing the consensus estimate from $3.30 to $3.72 [10] - For the next fiscal year, 6 estimates have moved higher while 2 have been revised downwards, indicating a generally positive earnings outlook [10] Group 4: Conclusion - Considering the positive momentum indicators and earnings outlook, MNDY is positioned as a strong buy candidate for investors seeking short-term gains [12]